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Abstract 
This paper examines the prevalence and determinants of multiple chronic diseases and their 
association with the self-rated health, functional health and quality of life among adults in six 
SAGE countries: China, India, Russia, South Africa Mexico and Ghana. We use ADL and IADL 
activities as measures of functional health and WHOQoL index as a measure of quality of life. 
Poisson regression models are estimated to understand the social determinants of multiple 
chronic diseases. Logit models and OLS are estimated to examine the association between 
multiple chronic morbidities and self-rated health, functional health and quality of life. Russia 
had the highest prevalence of multi-morbidity (32.8%, 95%CI=25.5-41.1) followed by South 
Africa (22%, 95%CI=17.7-26.9); the other four countries had prevalence of multi-morbidity 
around 21%. Measures of socioeconomic status: education and wealth were found negatively 
associated with the number of chronic diseases. Higher number of chronic conditions was 
associated with the poorer self rated health, functional health and WHOQoL. 
Introduction 
The present century is witnessing fundamental changes in its health and disease patterns due to 
rapid population ageing and epidemiological transition that ensues change from the 
predominance of parasitic and infectious diseases to chronic non communicable diseases among 
adult population (Omran, 1971; Joubert & Bradshaw, 2006). The onset of a chronic disease often 
leads to the simultaneous occurrence of various other health problems; therefore, with increasing 
longevity, multiple morbidities (defined as co-existence of two or more chronic diseases) 
become progressively common (Prados-Torres  et al, 2012). Evidences from both developed and 
developing countries show that older adults are at higher risk for multiple chronic 
diseases(Gijsen et al., 2001; Khanam et al., 2011; Salisbury, Johnson, Purdy, Valderas, & 
Montgomery, 2011; Salive, 2013; van den Akker, Buntinx, Metsemakers, Roos, & Knottnerus, 
1998; Walker, 2007). 
Multiple morbidities have been proven to be associated with adverse health outcomes, such as, 
reduced physical functions (Fried et al., 1999; Kadam & Croft, 2007) and quality of life (Fortin 
et al., 2004), poor self rated health (Galenkamp et al., 2011; Hoeymans et al., 1999), increased 
use of inpatient and ambulatory health care (Wolff et al, 2002; Salisbury et al., 2007) and in 
worst cases to mortality (Gijsen et al., 2001). Verbrugge and colleagues (1989) were the first to 
demonstrate the exponential increase in disability with increasing numbers of chronic diseases. 
Also, the prevalence of multiple morbidities increases the complexities of clinical decision and 
patient management and is consequently associated with higher medical care costs (Barnett et al., 
2012; Parekh & Barton, 2010). Therefore, people living with chronic and multiple chronic 
conditions often face higher out-of-pocket expenditure because of the need for longterm medical 
care. Overall, the rising prevalence of multiple morbidities and co-morbidities are known to raise 
the health care cost, add to the economic vulnerability of older adults and result in adverse effect 
on their physical and mental wellbeing further exacerbated by socioeconomic deprivation and 
poor medical care facilities (Lehnert et al., 2011; Marengoni et al., 2011; Tu, 2004).  
Given the pace of epidemiological transition and multiple effects of chronic diseases, various 
studies have evaluated the association of socioeconomic status (SES) with multiple morbidity 
and identified low level of education and poor economic status as risk factors (Khanam et al, 
2011; Uijen & Van de, 2008; Schafer et al, 2012). Chandola et al. (2007) showed that physical 
health deteriorated more rapidly with age among persons from the lowest occupational grade. 
Schäfer et. al., (2012) analyzed the association for German population and concluded that lower 
SES lead to a greater extent of multi-morbidity. The ample literature on multi-morbidity is, 
however, largely riveted to the developed world with a focus on elderly population considering it 
as the problem of aged population. In the year 2012, Agborsangaya et. al. extended the studies of 
multi morbidity to adult population and revealed that 70% of the individuals with multi-
morbidity belonged to less than 65 years of age group. There is still a virtual vacuum of studies 
focused on developing countries where the situation is more challenging with considerable 
burden of chronic conditions among adults younger than 60 years. At the same time, both 
demographic as well as epidemiological transition in the middle and low income countries are 
occurring at a much faster rate in a background of limited health care infrastructure. Second, 
these parallel transitions precede the progress in development and accumulation of wealth. The 
infectious and parasitic diseases are still a major concern but the increase in the prevalence of 
chronic diseases should not be overlooked. In general, there is limited awareness among these 
countries about the magnitude and consequences of non communicable diseases along with the 
limited capacity of the government to respond in a cost-effective manner with the existing health 
care system (Nugent, 2008). Therefore, this study based on adult population (aged 18 and above) 
of six low and middle income countries is an attempt to address these gaps.  
The six countries, namely, India, China, Ghana, Russia, South Africa and Mexico are at different 
stages of the demographic and epidemiological transitions. These nations are increasingly 
experiencing a rise in elderly population (except Russia) which has serious implications for the 
burden of disease as this age group is the most susceptible group for various morbidities (Bloom 
et al., 2011b; Dey et al., 2012; Williams & Krakauer, 2011; National Sample Survey 
Organisation, 2006). China is on the track to meet its MDGs target but has experienced a notable 
shift towards the epidemic of chronic and non-communicable diseases (NCDs) (Tang et al., 
2013). India, on the contrary, is still struggling with infectious and parasitic diseases with a 
considerable increase in the burden of chronic diseases (Bloom et al, 2013). Mexico has 
experienced a tremendous rise of 52% (from 23% to 75%) in the proportion of deaths from 
NCDs over a span of 50 years (Gonzalez et al, 2006). The government of Ghana though have 
recognized the growing burden of chronic disease since early 1990s; but it is yet to have a 
chronic disease policy or an integrated plan to deal with the issue (Bosu, 2012). The 
demographic changes in Russia in terms of increase in adult mortality and decline in life 
expectancy are mainly due to mortality from preventable causes including chronic diseases; still 
there is a lack of comprehensive programs for the their prevention (Chenet et al, 1998; Leon & 
Shkolnikov, 1998; Notzon et al., 1998;  Cockerham. 2000). South Africa is in the midst of a 
health transition characterized by a quadruple burden of communicable, non-communicable, 
perinatal and maternal, and injury-related disorders (Joubert & Bradshaw, 2006). The growing 
burden of NCDs demands concerted action from the government. Therefore, from this backdrop, 
the main objectives of this research work are: a) to examine the prevalence and determinants of 
multiple morbidities across the six SAGE countries; and b) to examine the association between 
multiple morbidities and other health conditions namely self-rated health, ADL, IADL and 
quality of life (WHOQoL) across the six SAGE countries.  
Data Sources: 
This study used the data from WHO-SAGE survey WAVE-1 for the analysis. SAGE is a 
longitudinal ageing study with nationally representative samples of adults from six countries: 
China, Ghana, India, Mexico, the Russian Federation and South Africa. Detailed description of 
study and sample design is provided in Kowal et al. (2012) (Kowal, Chatterji, Naidoo, Biritwum, 
& Wu, 2012). 
Methods 
Chronic conditions and multi-morbidity  
In this study, Multi-morbidity is defined as the simultaneous presence of two or more chronic 
condition at the time of data collection. We have included eight chronic health conditions 
namely: arthritis, stroke, angina pectoris, diabetes mellitus, asthma, hypertension, chronic lung 
disease and visual acuity. Among these, for arthritis, angina pectoris, asthma, lung disease, 
SAGE survey provides two types of measures: first, is self reports of the diagnosis of individual 
diseases and second is the symptom based assessment of aforementioned diseases. The specific 
question asked in SAGE for self reports is: “Have you ever been diagnosed with/told that you 
have disease name? Thus, we have considered an individual as suffering from these diseases if 
he is found positive in the symptom based assessment. For, stroke and diabetes mellitus we have 
relied on the self reports of diagnosis and for hypertension and visual acuity, we have used 
objective assessment.  
The measurement of hypertension is described as follows: In WHO-SAGE India 2007, three 
consecutive readings of blood pressure (systolic and diastolic both) have been taken. We have 
taken the mean of measured readings for each respondent to form a measure of blood pressure 
for both the indicators (systolic and diastolic). Further we have, classified hypertension 
according to the 1999 update of WHO/ISH guidelines for the management of hypertension. A 
summary of this update has been published in the Journal of Hypertension (ref: Journal of 
Hypertension. 2003 Nov; 21(11):1983-1992). Based on the abovementioned guideline, in this 
study, we have considered the limit of high systolic blood pressure to be 140mm/hg or above and 
of diastolic blood pressure to be 90mm/hg or above. An individual is considered to be 
hypertensive if he/she is measured to have either systolic or diastolic hypertension. 
Subjective health outcomes 
Self rated health 
Self rated health was asked on a five point scale:  very good, good, moderate, bad, and very bad. 
For the convenience of analysis, we combined bad and very bad health categories as ‘bad health’ 
and rest into other (good health) to derive a dichotomized health variable. ‘Bad health’ is the 
outcome of interest in the analysis. 
Functional health (ADL) 
Limitations in the activities of daily living (ADL) are used to assess the functional limitation. 
SAGE-Survey collected data on ADLs based on self- reports about particular activities in the last 
30 days on a five-point scale ranging from none to extreme difficulty. In this study, severe and 
extreme difficulties were combined to represent limitation in a particular activity. The ADLs 
include sitting, walking, standing-up, standing, climbing, crouching, picking up, eating, dressing, 
using toilet, moving around in home, transferring and concentrating for about 10 minutes. 
Quality of Life 
In SAGE QoL was assessed by asking respondents to rate their satisfaction with different 
domains of their lives (namely energy, money to meet needs, satisfaction with health, respondent 
himself, ability to perform activities of daily living, personal relationships, conditions of living 
place, life as a whole, and a five point scale of overall rating of quality of life) as well as rating 
their overall life satisfaction. Respondents were asked to respond on a five point scale ranging 
from very satisfied to very dissatisfied. A composite score was created by summing the 
responses across the different questions and rescaling the responses from 0-100 where a higher 
score indicated better quality of life. 
Statistical Methods 
The statistical analysis is carried out in two parts: first we have examined the correlates of multi-
morbidity (2-plus chronic disease) and one-plus chronic disease. Secondly, we have examined 
the association of multiple chronic conditions with the four of subjective health outcomes 
namely: 1-plus ADL limitations, depression, self rated poor health and WHOQoL index. 
Of the four measures of subjective health, 1-plus ADL limitations, depression, self rated poor 
health are binary outcome variables, therefore we have used the logit models to examine the 
association of chronic diseases with these indicators. The WHOQoL index is metric variable; 
therefore, we have used linear regressions. Further, all the regression are run on the pooled data 
from the six countries; therefore, the regression are estimated in the multilevel framework. 
Specifically, we have used random intercept multilevel (three level) regressions, where, country 
formed the highest level, state/province of residence formed the second level and individuals 
were at the first level. The multilevel analysis is performed using MLwin version 2.29. 
 Results  
This study analyzed the data on 42,489 individuals from WHO-SAGE wave-1 conducted in six 
middle-low income countries namely India, China, Ghana, Russia, South Africa and Mexico. 
Table1 presents the percentage distribution of the study population by socioeconomic and 
demographic characteristics from the six countries. Among the countries, Russia has the highest 
percentage of population aged 70 years and above (12.5%) while it is less than 10% for other 
countries. There are wide differentials among countries in the proportion of rural population 
ranging from 19% in Russia to 75% in India. The percentage of population with no schooling is 
highest in India (36.2) followed by Ghana (32.7) and lowest for Russia (0.3%). Similarly, the 
percentage of population with 10-plus years of schooling is highest for Russia (87%); whereas it 
is less than 30% for Ghana (29.4%), Mexico (25.7%) and India (26.8%). The study revealed 
considerable variations in the population distribution by wealth quintiles across the six countries. 
India and South Africa, however, reflected a fairly equitable distribution of adult population by 
wealth quintiles. The Chinese population depicted the largest heterogeneity in terms of 
household wealth as 10% of the adult population belonged to the household from the lowest 
wealth quintiles while 33% hail from the highest wealth quintiles.  
[Table1 around here] 
Table2 shows prevalence of any chronic disease, multi-morbidity (2-plus chronic diseases), 1-
plus ADL limitation, depression, self rated poor health and mean WHOQoL index (higher value 
represents better quality of life) based on the pooled sample of the six SAGE countries. Overall, 
the prevalence of morbidity-defined as the presence of at least one of the eight chronic diseases- 
was 53.3% (95%CI= 51.8-54.7) and the prevalence of multi-morbidity-defined as the presence of 
atleast 2-plus chronic conditions -was 21% (95%CI=20.0-21.9). Among the six countries, Russia 
had the highest prevalence of multi-morbidity (32.8%, 95%CI=25.5-41.1) followed by South 
Africa (22%, 95%CI=17.7-26.9); the other four countries had prevalence of multi-morbidity 
around 21%. The prevalence of atleast one chronic disease was highest in South Africa (69.1%, 
95%CI=61.9-75.5) followed by Ghana (61.8%, 95%CI=58.4-65.1) and lowest in India (50.6%, 
95%CI=48.9-52.4).  The consistent increase in the prevalence of both any morbidity (one 
disease) and multi-morbidity (two-plus disease) depicted the positive association with age where 
in 87% (95%CI= 84.7-88.4) of the population in the oldest age group (70-plus) had at least one 
chronic disease and 59% (95%CI=56.1-60.8) of them showed multi-morbidity. The measures of 
socioeconomic status - years of schooling and wealth quintiles- were negatively associated with 
the prevalence of morbidity and multi-morbidity with consistent decline in the prevalence by 
increasing levels of socioeconomic status. For example, prevalence of multi-morbidity and any 
one morbidity was 34% (95%CI=31.9-35.9) and 65% (95%CI=62.9-67.4) respectively among 
adults with no schooling compared with 15% (95%CI =13.2-17.5) and 44% (95%CI =40.9-46.7) 
prevalence among adults with 10-plus years schooling (table2).   
[Table2 around Here] 
Further, overall prevalence of measures of subjective health namely 1-plus ADL limitation, 
depression, self rated poor health and mean WHOQoL from the pooled data of six countries was 
14% (95%CI=13.2-14.8), 5.7% (95%CI=5.0-6.4), 11.6% (95%CI=10.9-12.4) and 54.4 
(95%CI=53.9-4.9) respectively. The prevalence of all the measures of subjective health appeared 
to be positively associated with age, that is, the prevalence was higher in the higher age groups. 
Contrarily, socioeconomic status was negatively associated with ADL, depression and self rated 
poor health and positively associated with mean WHOQoL index. For example, the prevalence 
of: any ADL limitation was 34% (95%CI=31.4-35.9) in no schooling group versus 6.3% 
(95%CI=5.5-7.2) in 10+ years of schooling group; depression was 12% (95%CI=10.6-13.5) in 
no schooling group versus 3.7% (95%CI=2.9-4.6) in 10+ years schooling group; self rated poor 
health was 18.6% (95%CI=17.2-20.1) in no schooling group versus 5.2% (95%CI=4.4-6.2) in 
the 10+ years of schooling group and Mean WHOQoL index was 51 (95%CI=50.1-51.9) for no-
schooling group versus 57.5 (95%CI=56.8-58.3) for 10+ years of schooling group. Similar 
patterns were observed for household wealth quintiles and such patterns point to the positive SES 
gradients of health. Results also depicted considerable cross country variations in the prevalence 
of 1+ADL, depression, self-rated poor health and Mean WHOQoL.  
The results in table2 also presents the prevalence of 1-plus ADL limitation, depression and self 
rated health along with mean WHOQoL index among adults with different number of chronic 
conditions. The table shows that with increasing number of chronic conditions, measures of 
subjective health become worse. For instance, percentage of adult population with 1+ADL 
increased from seven percent (no disease) to 59% (atleast four diseases); depression increased by 
nine times (three percent for no disease vs 27% for four diseases); self reported poor health 
increased from six percent to 49% and the mean WHOQoL declined from 57 to 43. 
We further examined the subjective health among those with one disease and multi-morbidity (2-
plus diseases) across selected socioeconomic and demographic groups. The results summarized 
in Table3 reveal that compared with adults having one chronic disease, multi-morbid adults had 
remarkably high prevalence of 1-plus ADL limitation (31.8%, 95%CI=29.7-33.9 vs. 12.1%, 
95%CI=11.1-13.2), depression (12.4%, 95%CI=11.0-13.9 vs. 4.9%, 95%CI=4.0-6.0), self rated 
poor health (26.1%, 95%CI=24.3-28.0 vs. 10.2%, 95%CI=9.0-11.6) and lower mean WHOQoL 
index (49.1, 95%CI=48.4-49.9 vs. 54.2, 95%CI=53.6-54.7).  Results show wide cross-country 
variations in the prevalence of measures of subjective wellbeing among adults with one chronic 
disease and with two-plus disease (multi-morbid) with poorer subjective health outcomes for 
multi-morbid adults. The maximum variation was observed for 1+ADL and depression with 
India having the highest prevalence of both 1-plus ADL limitation and depression (53%, 
95%CI=49.5-56.1 and 24%, 95%CI=21.3-26.5 respectively among multi-morbid and 26%, 
95%CI=23.4-28.5 and 11%, 95%CI=9.2-14.1 among those with one disease).  
[Table3 around here] 
Overall, the prevalence of multi-morbidity resulted in poorer subjective health outcomes across 
all the socioeconomic and demographic groups. The measures of SES revealed positive gradients 
for all the subjective health outcomes among both the multi-morbid adults and adults with one 
disease. However, the strength of the gradient varied between both the groups and across the 
indicators (table3).  
Correlates of chronic morbidity and multiple chronic morbidity 
Table4 presents the results of multi-level random intercept binary regressions to examine the 
correlates of 1-plus chronic diseases, 2-plus chronic diseases and 3-plus chronic diseases 
respectively. The results show that age is significantly and negatively associated with the all the 
three outcomes. Females were more likely to suffer from 2-plus and 3-plus chronic diseases 
(OR=1.06; p-value<0.1 and OR=1.12, p-value<0.05 respectively). Rural residence is 
significantly positively associated for atleast one chronic disease; but, it is statistically significant 
and negatively associated with prevalence of 2-plus and 3-plus chronic diseases. The SES 
measured by years of schooling and household wealth quintiles show negative gradients with 
prevalence of all three outcomes. That is, the likelihood of one, 2-plus and 3-plus chronic 
diseases declined with the increasing levels of socioeconomic status. Among the health risk 
factors, obesity, high risk waist-hip ratio and low physical activity (inactivity) is associated with 
the higher prevalence of single and multiple chronic diseases.   
Association of multi-morbidity with the subjective health outcomes 
In this section, we describe the relationship between multiple morbidity and subjective health 
outcomes: 1-plus ADL limitation, depression, self-rated poor health and WHOQoL index. The 
analysis is performed in two steps. First, we examined the effects of absolute number of diseases 
on selected subjective health outcomes after adjusting for the social, demographic and health risk 
factors. In the next step, we examined the independent effects of each disease and each pair of 
diseases on each of the subjective health outcomes. The regressions are estimated in the 
multilevel framework. 
The effects of increasing level of multi-morbidity (number of chronic diseases) on the subjective 
health outcomes (ADL, depression, self rated health and WHOQoL) are shown in table5. The 
table5 presents both adjusted (for control variables) and unadjusted estimates for each of health 
outcome. The results show that higher number of chronic diseases has a statistically significant 
effect on the subjective health outcomes which declines manifold with the increasing number of 
chronic diseases. Moreover, for each of the ADL limitations, depression and self rated poor 
health; the adjusted odds appear to be similar.  Those with three chronic diseases are more than 4 
times as likely to have 1-plus ADL, depression and poor self rated health as ones with no 
diseases. The WHOQoL index declines by 6 points for individuals with 3 chronic diseases 
compared with the individuals with no diseases. Compared with adults with no disease, those 
with 4 or more diseases are almost 7 times more likely to have 1-plus ADL limitations, 
depression and poor self rated health.  
[Table5 around here] 
Table6 presents the regression results showing association of diseases and disease pairs on each 
of the chronic diseases. The model1 in table6 shows effects of individual chronic diseases on 
subjective health outcomes after adjusting for the effects of other diseases and the control 
variables. The model 2 presents main effects as well as the interactions of the pairs of the chronic 
diseases. Results from model1 show that all the diseases except hypertension had statistically 
significant negative effects on the subjective health outcomes. For example, adults with arthritis 
are more than two times more likely to have 1-plus ADL and depression and 1.8 times more 
likely to report poor health. The effect on WHOQoL index is also negative where, WHOQoL 
index declined by 3 points among persons with arthritis. Other diseases like angina, lung 
diseases, low vision, diabetes and stroke showed similar negative effects on health outcomes.  
[Table6 around here] 
Results from the model2 shows that the main effects on the different subjective health outcomes 
for all the diseases except hypertension were significant and negative. That is, the subjective 
health is worse in the presence of chronic diseases. The main effects indicate the effect of each 
disease on a person suffering from none of the other conditions.  The interaction estimates for 
pairs of diseases present a mixed picture as only few of the interactions emerged to be 
statistically significant and some of the interactions of disease pairs were positive, while, some 
were negative. A positive interaction (odds ratio greater than one in logit models of ADL 
limitations, depression and poor self rated health and negative coefficients in linear regressions 
for WHOQoL index) show that the combined effect of two diseases disease is more than the 
additive effect of each one of them individually; while a negative interaction (odds ratio less than 
one in logit models of ADL limitations, depression and poor self rated health and positive 
coefficients in linear regressions for WHOQoL index) indicates that the effect of the two 
diseases is less than the additive effect of each of them individually. The positive interactions 
show synergistic effects of the pair of diseases and the negative interactions show antagonistic 
effects. Regression results for one ADL limitations show that the interactions of hypertension-
angina, hypertension-diabetes, arthritis-angina, arthritis-lung diseases, arthritis-asthma, arthritis-
low vision, angina-lung diseases, angina-asthma and low vision-diabetes showed statistically 
significant interactions; of which the interaction of hypertension-diabetes was synergistic. For 
depression, the interactions of hypertension-angina, arthritis-angina, arthritis-lung diseases, 
angina-diabetes, lung diseases-asthma and low vision diabetes were statistically significant; but 
no synergistic interactions emerged. For, self rated poor health, hypertension-asthma, arthritis-
angina, arthritis-lung diseases, arthritis-asthma, angina-lung disease, angina-low vision, lung 
diseases-diabetes, asthma-diabetes and low vision-diabetes were statistically significant; out of 
these significant interactions only hypertension- asthma was synergistically associated with poor 
self rated health. Similarly for the WHOQoL index, hypertension-asthma, arthritis-angina, 
arthritis-lung disease, arthritis-asthma, arthritis-diabetes, angina-lung diseases, low vision-
diabetes were and significant and hypertension-asthma showed synergistic interaction.  
Discussion 
In this study, we explored the prevalence and correlates of multi morbidity among adult 
population across six developing countries and its association with functional health and well 
being. In the first stage of analysis, the study measured the prevalence of multi-morbidity, 1+ 
morbidity, 1+ADL, depression, self rated poor health and mean WHOQoL score on the pooled 
sample of six countries. We assessed the change in measures of functional health and well being 
in the presence of one disease and 2+ morbidities. In the second stage, we estimated correlates of 
atleast one morbidity and multi-morbidity. In the last stage, we evaluated the effect of increasing 
number of diseases, individual diseases, namely arthritis, stroke, angina pectoris, diabetes 
mellitus, asthma, hypertension, chronic lung disease and visual acuity as well as the interaction 
effect of these diseases on functional limitation, depression, self rated health and quality of life 
using random intercept multilevel (three level) regressions.   
Results reveal that more than half of the adults had at least one disease and around one fifth had 
two or more (multi-morbidity) diseases out of the eight chronic diseases. Among the six 
countries, Russia has the highest prevalence of multi morbidity which is one of the reasons for 
high adult mortality in the country (Cockerham, 2000). India has the highest prevalence of 
1+ADL limitation and depression among its adult population. The study reflected a positive 
association of age with multi morbidity and measures of subjective well being; the increase in 
the number of chronic diseases is further positively associated with adverse functional health and 
poor quality of life. The issues of disabilities become prominent in old age than longevity (Fried 
et.al, 1999; Cutler, 2003) because people with functional limitation need constant care and 
support and are at an increased risk of being hospitalized (Melzer et.al, 1999). 
The results reveal negative association of socioeconomic factors with the prevalence of chronic 
diseases which remains true for multiple morbidities, which is consistent with the findings of 
previous research work (Marengoni et.al, 2011; Schafer et.al, 2012; Agborsangaya et.al, 2012; 
Fried et.al, 1999). The prevalence of 1+ ADL limitation, depression and poor self rated health 
declines and WHOQol score increases with the improvement in the level of education and wealth 
status. The study presented an interesting finding as adults with multiple morbidities have poorer 
functional health and subjective well being as compared to adults with one chronic disease 
irrespective of their socioeconomic status.  
The study further investigated the correlates of one chronic diseases, 2-plus chronic diseases and 
3-plus chronic diseases. We replicate the results of Kirchberger et.al, 2012; Marengoni et.al, 
2011; Schram et.al, 2008 and Agborsangaya et.al, 2012 to conclude that multi morbidity is 
significantly higher among older people, women and individuals of low socioeconomic status 
(measured in terms of years of schooling and household economic status). We further identified 
obesity, high risk waist-hip ratio and low physical activity as the risk factors for single and 
multiple chronic diseases.  
This study makes an important contribution in the field of epidemiology by extending the  
analysis to examine the effect of multiple chronic diseases on functional health and quality of life 
among adult population, along with assessing the interaction effect of the eight selected chronic 
diseases. The study revealed that increase in number of chronic diseases leads to manifold 
increase in the functional impairments, depression and self rated poor health. The quality of life 
declines rapidly with increasing number of morbidities. Further, when we analyzed the 
interaction estimates according to the pair of eight chronic diseases, we found a very assorted 
picture. The interaction effect explains whether the effect of two diseases is more than or less 
than the additive effect of each disease individually. Only a few of the interactions were 
significant; some of them had synergistic effect, while others have antagonistic effect. Among all 
the pair of diseases, the interactions of hypertension with any of the chronic diseases have 
depicted significant association. The interaction effect of hypertension-diabetes is more than 
their additive effect on 1-plus ADL limitation. The pair of hypertension-asthma was 
synergistically associated with self rated poor health and WHOQoL index. The study did not find 
any significant synergistic interactions for depression.  
The identification of these interaction effects of chronic diseases is essential for prevention and 
for planning optimum resource allocation. Chronic diseases tend to have multiple effects on an 
individual viz-a-viz from poor functional health and well being to increasing the vulnerability for 
various other morbidities as well as exerting a burden on financial resources. These findings can 
help in the aversion of chronic diseases and minimize the likelihood of second disease when a 
specific disease is already present. This study adds significantly to the literature in terms of 
revealing the vulnerability of adult population to multiple morbidities as well as the adverse 
effect of presence of one chronic disease and multiple morbidities on an individual. In 
developing countries, the health care financing and allocation of health care resources is a major 
challenge. The burden of chronic diseases is preventable and can be controlled if due attention is 
given to them and interventions are made on time. 
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Table1: Characteristics of sample population from WHO-SAGE Wave1 Data 
  
India China Ghana Mexico Russia 
South 
Africa 
All 
Countries 
Male 
(pooled) 
Female 
(pooled) 
N 11,230 14,813 5,110 2,756 4,355 4,225 42,489 18,327 24,144 
Age Group           
18-49 (%) 75.2 74.2 75.4 73.6 58.7 75.9 70.7 71.8 69.5 
50-59 (%) 12 11.6 9.8 12.7 18.7 12 14.6 14.5 14.7 
60-69 (%) 7.7 8.2 6.8 6.8 10.2 7.4 8.4 8.2 8.6 
70+ (%) 5.1 6 8.1 7 12.5 4.7 6.4 5.6 7.2 
Sex         
  
Male (%) 50.9 50.9 50 48 45 47.2 50.7 - -  
Female (%) 49.1 49.1 50 52 55 52.8 49.3 - -  
Residence         
  
Urban (%) 25.5 48.5 45.8 77.8 81.5 69.3 44.6 44.0 45.2 
Rural (%) 74.5 51.5 54.2 22.2 18.5 30.7 55.4 56.0 54.8 
Marital status         
  
Never Married (%) 9.4 5.7 8.4 21.3 12.8 31 8.4 10.5 6.3 
Currently Married 
/Cohabiting (%) 81.9 89 72.6 69.6 61.1 52.8 83.3 85.3 81.3 
Widowed/Divorced 
/Separated (%) 8.7 5.3 19 9.1 26 16.1 8.3 4.2 12.4 
years of schooling         
  
No schooling (%) 36.2 8.4 32.7 5.9 0.3 7.8 18.3 11.3 25.6 
1-5 years (%) 17.6 16 9.6 20.2 2.4 15.1 16.2 15.6 16.9 
6-9 years (%) 19.4 46.2 18.9 48.3 10.3 26.9 33.5 35.6 31.5 
10+ years (%) 26.8 29.4 38.8 25.7 87 50.2 31.9 37.6 26.1 
Wealth quintile         
  
Lowest (%) 20.6 9.8 15.3 16.5 12.7 18.9 14.3 14.5 14.1 
Second (%) 21.2 15.9 17.9 23.3 12.8 19.5 17.9 17.7 18.0 
Middle (%) 19.9 18.3 19.1 20.1 16.5 20.5 19.0 20.1 17.9 
Fourth (%) 18.0 23.4 22.6 15.4 23.5 19.4 21.3 20.7 21.8 
Highest(%) 20.2 32.6 25.2 24.6 34.5 21.8 27.6 27.0 28.2 
All the percentages are weighted by sampling weights.  
 
 
 
 
 
 
Table2: Mean number of diseases, Morbidity and Multi-morbidity prevalence (%) and measures of 
subjective wellbeing by background characteristics, WHO-SAGE Wave1  
Background 
Variables 
Mean 
Number 
of 
diseases 
Multi-
morbidity 
(%) 
1+ 
morbidity 
(%) 
1+ADL 
(%) 
Depression 
(%) 
Self rated 
poor 
health 
(%) 
Mean  
WHOQoL 
Age Group  
      
  
18-49 
0.6 
(0.6-0.6) 
11.9 
(10.9-13.0) 
42.9 
(41.0-44.7) 
9.1 
(8.2-10.0) 
4.9 
(4.2-5.7) 
7.4 
(6.5-8.5) 
55.4 
(54.9-55.9) 
50-59 
1.2 
(1.2-1.2) 
32.9 
(31.3-34.6) 
72.4 
(70.6-74.1) 
16.8 
(15.5-18.3) 
6.4 
(5.1-7.9) 
16.2 
(15.0-17.5) 
53.3 
(52.8-53.8) 
60-69 
1.6 
(1.6-1.6) 
47.9 
(46.3-49.6) 
82.2 
(80.9-83.5) 
27.7 
(25.9-29.6) 
8.2 
(7.2-9.3) 
22.3 
(20.6-24.1) 
51.5 
(50.8-52.3) 
70+ 
1.9 
(1.8-2.0) 
58.5 
(56.1-60.8) 
86.6 
(84.7-88.4) 
44 
(41.7-46.4) 
9.6 
(8.4-10.9) 
33.6 
(31.6-35.6) 
49.2 
(48.4-50.0) 
Sex        
Male 
0.8 
(0.8-0.8) 
18.4 
(17.1-19.7) 
52.5 
(50.4-54.6) 
10.1 
(9.1-11.2) 
4.7 
(4.0-5.6) 
10.1 
(9.1-11.3) 
55.1 
(54.6-55.7) 
Female 
0.9 
(0.9-0.9) 
23.6 
(22.4-24.9) 
54.1 
(52.3-55.9) 
18 
(16.8-19.2) 
6.7 
(5.9-7.5) 
13.1 
(12.2-14.1) 
53.7 
(53.1-54.2) 
Residence        
Urban 
0.8 
(0.7-0.8) 
19.3 
(17.6-21.2) 
49.9 
(47.5-52.3) 
10 
(8.7-11.4) 
5 
(3.9-6.4) 
8.4 
(7.5-9.4) 
55.5 
(54.7-56.2) 
Rural 
0.9 
(0.9-0.9) 
22.2 
(21.2-23.3) 
56 
(54.2-57.7) 
17.2 
(16.2-18.3) 
6.2 
(5.6-7.0) 
14.2 
(13.1-15.3) 
53.5 
(53.0-54.1) 
Years of schooling        
No schooling 
1.2 
(1.1-1.2) 
33.9 
(31.9-35.9) 
65.2 
(62.9-67.4) 
33.6 
(31.4-35.9) 
12 
(10.6-13.5) 
18.6 
(17.2-20.1) 
51 
(50.1-51.9) 
1-5 years 
1 
(1.0-1.1) 
26.7 
(24.5-29.1) 
62.4 
(59.7-65.0) 
18.7 
(16.5-21.1) 
5.8 
(4.7-7.2) 
18.6 
(16.2-21.2) 
51.7 
(50.9-52.5) 
6-9 years 
0.8 
(0.7-0.8) 
16.8 
(15.4-18.3) 
51.5 
(49.0-53.9) 
8.7 
(7.6-9.9) 
4.3 
(3.5-5.4) 
10.6 
(9.2-12.2) 
54.3 
(53.7-54.9) 
10+ years 
0.7 
(0.6-0.7) 
15.2 
(13.2-17.5) 
43.7 
(40.9-46.7) 
6.3 
(5.5-7.2) 
3.7 
(2.9-4.6) 
5.2 
(4.4-6.2) 
57.5 
(56.8-58.3) 
Income quintile        
Lowest 
1 
(1.0-1.1) 
27.5 
(25.2-30.0) 
59 
(56.4-61.6) 
24.2 
(21.7-26.9) 
8.5 
(7.0-10.2) 
19.4 
(17.3-21.6) 
48 
(47.2-48.8) 
Second 
0.9 
(0.8-1.0) 
22.7 
(20.8-24.7) 
56.4 
(53.3-59.4) 
18.5 
(16.5-20.6) 
6.7 
(5.6-8.0) 
15 
(13.3-16.8) 
52.1 
(51.4-52.8) 
Middle 
0.9 
(0.8-0.9) 
21.2 
(19.1-23.4) 
54.7 
(50.8-58.5) 
14.3 
(12.8-16.0) 
6.5 
(5.4-7.8) 
13.9 
(12.3-15.6) 
53.7 
(53.0-54.5) 
Fourth 
0.9 
(0.8-0.9) 
20.9 
(18.9-23.0) 
55.6 
(52.2-59.0) 
11.1 
(9.8-12.6) 
5.2 
(4.0-6.7) 
10.2 
(8.7-12.0) 
55.6 
(54.8-56.4) 
Highest 
0.7 
(0.6-0.7) 
16.2 
(14.4-18.2) 
45.5 
(42.6-48.4) 
7.6 
(6.6-8.7) 
3.5 
(2.8-4.3) 
4.9 
(4.0-6.0) 
58.7 
(58.0-59.4) 
Country        
India 
0.8 
(0.8-0.9) 
20.8 
(19.4-22.3) 
50.6 
(48.9-52.4) 
26.2 
(24.6-27.9) 
11.6 
(10.1-13.2) 
10.9 
(9.8-12.1) 
53.7 
(53.1-54.4) 
China 
0.8 
(0.8-0.9) 
19.7 
(18.4-21.0) 
54 
(51.7-56.3) 
5.6 
(4.9-6.2) 
1.6 
(1.2-2.2) 
12.5 
(11.4-13.6) 
54.9 
(54.2-55.6) 
Ghana 
0.9 
(0.8-1.0) 
21.6 
(19.0-24.6) 
61.8 
(58.4-65.1) 
16.7 
(14.7-18.9) 
5.2 
(4.0-6.7) 
8.9 
(7.4-10.8) 
52.3 
(51.4-53.1) 
Mexico 
0.8 
(0.7-1.0) 
21.2 
(17.5-25.4) 
52.4 
(45.0-59.8) 
19 
(14.6-24.4) 
9.3 
(6.5-13.1) 
6.9 
(4.6-10.2) 
55.3 
(53.8-56.9) 
Russia 
1.2 
(1.0-1.4) 
32.8 
(25.5-41.1) 
57.9 
(49.7-65.7) 
11.6 
(9.4-14.1) 
4.9 
(3.6-6.7) 
11.3 
(8.6-14.7) 
53.5 
(52.2-54.9) 
South Africa 
1 
(0.9-1.1) 
22 
(17.7-26.9) 
69.1 
(61.9-75.5) 
19.4 
(14.9-24.9) 
5 
(2.5-9.9) 
9.7 
(7.0-13.3) 
53.8 
(51.7-55.8) 
Number of 
diseases        
0    
7.2 
(6.3-8.2) 
3.2 
(2.6-4.0) 
6 
(5.0-7.1) 
56.90215 
(56.3-57.5) 
1    
12.1 
(11.1-13.2) 
4.9 
(4.0-6.0) 
10.2 
(9.0-11.6) 
54.17647 
(53.6-54.7) 
2    
25.2 
(22.8-27.7) 
9.7 
(8.2-11.6) 
19.1 
(17.1-21.1) 
51.03618 
(50.2-51.9) 
3    
37.7 
(34.1-41.4) 
12.7 
(10.4-15.5) 
35 
(31.6-38.6) 
46.71486 
(45.6-47.8) 
4+    
58.6 
(53.2-63.9) 
27 
(22.3-32.3) 
49.4 
(44.6-54.2) 
42.97506 
(41.6-44.3) 
Total 
0.8 
(0.8-0.9) 
20.9 
(20.0-21.9) 
53.3 
(51.8-54.7) 
14 
(13.2-14.8) 
5.7 
(5.0-6.4) 
11.6 
(10.9-12.4) 
54.4 
(53.9-54.9) 
Notes: % estimates are weighted by the pooled country weight and figures in the parentheses are the 
95% confidence intervals.  
 
Table3: Prevalence of 1+ADL limitations, Depression, Self rated poor health and Mean WHOQoL index 
among adults with one diseases and 2 or more diseases, WHO-SAGE Wave1 
  
1 disease 2+ morbidity 
1+ ADL  
(%) 
Depression  
(%) 
Self rated 
poor health  
(%) 
 Mean 
WHOQoL 
1+ ADL  
(%) 
Depression  
(%) 
Self rated 
poor health  
(%) 
 Mean 
WHOQoL 
Age Group         
   
  
18-49 
8.3 
(7.0-9.7) 
4.6 
(3.6-5.8) 
7.3 
(5.7-9.4) 
54.8 
(54.1-55.5) 
24.9 
(21.1-29.0) 
14.6 
(11.8-17.9) 
17.5 
(13.8-21.9) 
50.2 
(48.9-51.4) 
50-59 
14.2 
(12.6-15.9) 
4.5 
(3.2-6.4) 
13.6 
(12.1-15.2) 
54 
(53.3-54.6) 
25.5 
(23.1-28.1) 
11.1 
(9.2-13.3) 
25.4 
(23.1-27.8) 
49.9 
(49.1-50.6) 
60-69 
21.3 
(19.1-23.6) 
5.8 
(4.6-7.4) 
16 
(14.2-18.0) 
52.8 
(52.0-53.6) 
37.3 
(34.4-40.2) 
10.9 
(9.5-12.4) 
31.7 
(28.9-34.6) 
48.3 
(47.5-49.2) 
70+ 
37.5 
(33.9-41.2) 
9.1 
(7.1-11.8) 
26 
(23.1-29.1) 
49.6 
(48.6-50.6) 
49.6 
(46.8-52.4) 
10.4 
(8.9-12.0) 
40.8 
(38.1-43.4) 
46.7 
(45.8-47.7) 
Sex   
  
  
   
  
Male 
8.4 
(7.2-9.9) 
3.6 
(2.6-5.2) 
8.2 
(6.8-10.0) 
55 
(54.3-55.7) 
26.3 
(22.9-29.9) 
11.7 
(9.6-14.3) 
24.3 
(21.4-27.3) 
49.7 
(48.8-50.6) 
Female 
16.3 
(14.8-18.1) 
6.4 
(5.3-7.6) 
12.6 
(10.6-14.8) 
53.2 
(52.4-54.0) 
36.2 
(34.1-38.5) 
12.8 
(11.2-14.5) 
27.7 
(25.7-29.7) 
48.7 
(47.7-49.6) 
Residence   
  
  
   
  
Urban 
8.5 
(7.0-10.2) 
4.7 
(3.2-6.8) 
6.4 
(4.9-8.3) 
55.2 
(54.2-56.2) 
26 
(22.4-30.1) 
11.4 
(9.1-14.2) 
23 
(20.0-26.4) 
49.9 
(48.6-51.3) 
Rural 
14.8 
(13.4-16.2) 
5.1 
(4.2-6.2) 
13.1 
(11.4-15.0) 
53.4 
(52.8-54.1) 
35.8 
(33.6-38.1) 
13 
(11.4-14.7) 
28.3 
(26.2-30.5) 
48.6 
(47.7-49.4) 
years of 
schooling 
  
  
  
   
  
No schooling 
31.3 
(28.1-34.7) 
11 
(8.9-13.5) 
15.2 
(13.4-17.3) 
51 
(50.2-51.9) 
48.5 
(45.4-51.6) 
16.8 
(14.8-18.9) 
30.7 
(28.5-33.0) 
46.7 
(45.9-47.6) 
1-5 years 
15 
(12.1-18.3) 
4.4 
(3.0-6.3) 
15 
(11.0-20.1) 
52.9 
(51.7-54.0) 
35.8 
(31.8-40.1) 
11.4 
(8.7-14.8) 
32.4 
(29.0-35.9) 
48.7 
(47.4-50.0) 
6-9 years 
7 
(5.6-8.6) 
3.7 
(2.5-5.4) 
9.1 
(7.1-11.6) 
54.2 
(53.1-55.3) 
22 
(17.8-26.8) 
9.2 
(6.8-12.4) 
27 
(22.4-32.2) 
49.2 
(48.0-50.4) 
10+ years 
5 
(3.9-6.5) 
3.1 
(2.0-4.7) 
5.3 
(3.8-7.3) 
56.8 
(55.9-57.8) 
18.2 
(14.8-22.3) 
11.1 
(8.2-14.9) 
13.8 
(11.3-16.8) 
52.5 
(50.9-54.1) 
Wealth quintile   
  
  
   
  
Lowest 
22.7 
(19.2-26.5) 
7.1 
(4.9-10.2) 
16.8 
(14.0-20.1) 
48.4 
(47.1-49.6) 
41.5 
(37.5-45.6) 
15.1 
(12.4-18.3) 
36.1 
(32.3-40.2) 
43.4 
(42.2-44.7) 
Second 
16.1 
(13.4-19.3) 
6.1 
(4.6-8.0) 
11.8 
(8.9-15.3) 
52.3 
(51.2-53.4) 
35.4 
(31.4-39.5) 
13.1 
(10.8-15.9) 
29.3 
(25.6-33.4) 
47.7 
(46.6-48.8) 
Middle 
10.8 
(8.9-13.0) 
5.1 
(3.6-7.2) 
12.2 
(9.6-15.5) 
54 
(52.9-55.1) 
35.6 
(31.4-40.0) 
14.1 
(11.0-18.0) 
30.2 
(26.6-34.0) 
48.6 
(47.3-50.0) 
Fourth 
9 
(7.4-10.9) 
5 
(3.1-8.2) 
9.9 
(7.4-13.2) 
54.7 
(53.6-55.9) 
25.5 
(21.7-29.7) 
10 
(7.4-13.3) 
21.2 
(18.3-24.4) 
51.5 
(50.2-52.9) 
Highest 
7 
(5.7-8.5) 
2.6 
(1.8-3.8) 
4.2 
(2.9-5.9) 
58.5 
(57.6-59.4) 
22.8 
(18.5-27.8) 
10.1 
(7.4-13.5) 
15.8 
(11.2-21.7) 
53.4 
(51.5-55.2) 
Country   
  
  
   
  
India 
25.9 
(23.4-28.5) 
11.4 
(9.2-14.1) 
9.6 
(8.2-11.1) 
53.8 
(53.1-54.6) 
52.8 
(49.5-56.1) 
23.8 
(21.3-26.5) 
23.8 
(21.3-26.4) 
48.1 
(47.2-49.0) 
China 
3.9 
(3.2-4.7) 
1 
(0.5-1.9) 
11.2 
(9.4-13.4) 
54.6 
(53.7-55.4) 
17.1 
(14.7-19.9) 
4.7 
(3.3-6.7) 
29.2 
(26.3-32.2) 
49.9 
(48.6-51.1) 
Ghana 
15.3 
(12.5-18.6) 
4.1 
(2.7-6.2) 
6.8 
(4.8-9.5) 
53.5 
(52.2-54.8) 
30.8 
(26.0-36.1) 
10.7 
(7.8-14.7) 
16.9 
(13.4-21.1) 
46.3 
(44.5-48.0) 
Mexico 
23.3 
(14.6-35.1) 
9.8 
(5.8-15.8) 
6.7 
(3.5-12.6) 
52.7 
(49.4-55.9) 
35.6 
(27.5-44.6) 
17.1 
(10.3-27.0) 
19.1 
(12.0-29.0) 
50.7 
(48.1-53.4) 
Russia 
8.1 
(4.9-13.1) 
3.8 
(1.9-7.5) 
8.1 
(4.6-14.0) 
52.5 
(50.5-54.5) 
26.9 
(21.3-33.4) 
8.8 
(6.1-12.5) 
23 
(18.4-28.3) 
49.3 
(47.1-51.5) 
South Africa 
10.2 
(6.8-14.9) 
3 
(1.4-6.4) 
5.3 
(2.8-9.6) 
55.1 
(53.0-57.2) 
46.9 
(37.1-57.0) 
6.9 
(4.3-10.8) 
20.2 
(14.4-27.5) 
45.3 
(40.3-50.4) 
Total 
12.1 
(11.1-13.2) 
4.9 
(4.0-6.0) 
10.2 
(9.0-11.6) 
54.2 
(53.6-54.7) 
31.8 
(29.7-33.9) 
12.4 
(11.0-13.9) 
26.1 
(24.3-28.0) 
49.1 
(48.4-49.9) 
 
 
 
 
 
 
 
 
 
 
 
Figure1: Percentage distribution of sample population by number of chronic diseases across countries 
(Panel A) and across broad age groups (Panel B), WHO-SAGE Wave1 2007 
 
 
 
 
 
 
 
 
 
Table4: Correlates of at least one morbidity and multimorbidity (2+morbidity & 3+multimorbidity) 
Predictors 
1+ Disease 2+ disease 3+ disease 
OR OR OR 
Age 
  
  
18-49 
  
  
50-59 3.25***(3.04-3.47) 3.12***(2.88-3.37) 3.18***(2.75-3.66) 
60-69 5.33***(4.91-5.76) 5.24***(4.83-5.7) 5.91***(5.1-6.82) 
70+ 7.55***(6.81-8.29) 7.53***(6.9-8.26) 8.4***(7.17-9.75) 
Sex 
   Male 
   Female 0.99(0.91-1.07) 1.06*(0.99-1.14) 1.12**(1.02-1.21) 
Residence 
   Urban  
   Rural 1.05*(0.98-1.11) 0.96*(0.91-1.01) 0.85***(0.79-0.9) 
Marital Status 
   Never Married 
   Currently 
married/cohabiting 
1.51***(1.33-1.7) 1.31***(1.14-1.47) 1.49***(1.26-1.75) 
Widowed/Divirced 1.78***(1.56-2.03) 1.45***(1.26-1.64) 1.62***(1.36-1.9) 
Years of schooling 
   No Schooling 
   1-5 years 0.93**(0.86-1.01) 0.93**(0.87-1) 1.02(0.93-1.11) 
6-9 years 0.76***(0.7-0.82) 0.81***(0.76-0.87) 0.86**(0.78-0.95) 
10+ years 0.61***(0.55-0.66) 0.64***(0.6-0.69) 0.66***(0.59-0.74) 
Wealth Quintile 
   Lowest 
   Lower 1.04(0.95-1.13) 0.97(0.9-1.04) 0.89**(0.81-0.98) 
Middle 1.07*(0.98-1.17) 0.96(0.89-1.03) 0.93*(0.84-1.02) 
Higher 0.96(0.87-1.04) 0.89***(0.82-0.95) 0.85***(0.77-0.94) 
Highest 0.92**(0.84-1.01) 0.82***(0.76-0.89) 0.73***(0.66-0.81) 
Waist-hip ratio 
   High risk 1.25***(1.16-1.34) 1.25***(1.17-1.32) 1.2***(1.11-1.28) 
Otherwise 
   Body Mass Index 
   Obese 1.75***(1.58-1.94) 1.59***(1.48-1.71) 1.65***(1.51-1.8) 
Otherwise 
   Physical Activity 
   Active 
   Inactive 1.09**(1.02-1.16) 1.13***(1.07-1.19) 1.24***(1.17-1.32) 
Daily Tobacco 
Consumption    No 
   Yes 1.01(0.94-1.08) 0.99(0.93-1.06) 1.01(0.93-1.09) 
Alcohol Consumption 
   No 
   Yes 1.13**(1.03-1.23) 1.04(0.96-1.12) 0.95(0.85-1.07) 
cons 0.74**(0.52-1) 0.14***(0.1-0.21) 0.03***(0.02-0.05) 
Random Part 
   Country level variance 0.13(0.01-0.52) 0.2(0.04-0.7) 0.52(0.1-1.89) 
Province level variance 0.18(0.12-0.28) 0.18(0.11-0.26) 0.14(0.09-0.22) 
 
 
 
Table5: Multilevel Logit Model to examine the effects of count of disease on the measures of subjective 
health, SAGE wave 1 
Number of 
chronic 
diseases 
ADL Depression SRH WHOQoL 
Unadjusted 
OR 
Adjusted 
OR 
Unadjusted 
OR 
Adjusted 
OR 
Unadjusted 
OR 
Adjusted 
OR 
Unadjusted 
beta Adjusted beta 
No disease 
       
  
1 disease 
2.07*** 
(1.93-2.22) 
1.51*** 
(1.38-1.65) 
1.77*** 
(1.57-2.01) 
1.62*** 
(1.42-1.84) 
1.9*** 
(1.74-2.08) 
1.5*** 
(1.35-1.65) 
-4.26*** 
(-4.58--3.94) 
-1.28*** 
(-1.59--0.98) 
2 disease 
4.08*** 
(3.78-4.39) 
2.47*** 
(2.26-2.72) 
2.8*** 
(2.48-3.18) 
2.44*** 
(2.14-2.82) 
3.38*** 
(3.09-3.69) 
2.25*** 
(2.03-2.5) 
-7.38*** 
(-7.73--7.03) 
-3.11*** 
(-3.46--2.77) 
3 disease 
7.28*** 
(6.66-7.92) 
3.81*** 
(3.42-4.26) 
4.74*** 
(4.12-5.46) 
4.05*** 
(3.47-4.75) 
6.33*** 
(5.71-6.98) 
4.03*** 
(3.59-4.5) 
-10.74*** 
(-11.19--10.28) 
-5.79*** 
(-6.23--5.35) 
4+ disease 
15.18*** 
(13.58-16.83) 
7.21*** 
(6.33-8.17) 
8.75*** 
(7.53-10.12) 
7.33*** 
(6.24-8.61) 
12.3*** 
(10.99-13.71) 
7.38*** 
(6.43-8.38) 
-14.6*** 
(-15.16--14.03) 
-8.93*** 
(-9.48--8.38) 
Country 
0.69 
(0.17-2.36) 
1.24 
(0.3-4.24) 
0.73 
(0.16-2.52) 
0.73 
(0.16-2.52) 
0.16 
(0.03-0.55) 
0.3 
(0.07-0.97) 
7.41 
(-1.93-16.76) 
5.99 
(-1.24-13.22) 
Province/state 
0.24 
(0.16-0.35) 
0.3 
(0.21-0.44) 
0.43 
(0.28-0.64) 
0.43 
(0.28-0.64) 
0.17 
(0.11-0.24) 
0.21 
(0.14-0.3) 
8.57 
(5.68-11.46) 
3.99 
(2.49-5.49) 
Individual na na na na na na 
163.83 
(161.6-166.0) 
120.68 
(118.9-122.4) 
Notes: * p<.1, ** p<.05, *** p<.01; Figures in the parentheses are 95% credible intervals; Adjusted ORs 
are controlled for the effects of background characteristics and health risk factors. na= not applicable. 
Estimates are obtained through MCMC algorithm available in the MLWin. 
 
Table6: Multi level regression estimates showing the effects of combinations of chronic diseases on measures of subjective 
health (1+ADL limitation, Depression, SRH and WHOQoL index), SAGE wave 1 
  
ADL Depression SRH WHOQoL 
OR  
(95% CI) 
OR  
(95% CI) 
OR  
(95% CI) 
Beta coefficient  
(95% CI) 
Model1  Model2 Model1  Model2 Model1  Model2 Model1  Model2 
Main Effects 
       
  
Arthritis 
2.15*** 
(1.99-2.32) 
2.75*** 
(2.43-3.12) 
2.06*** 
(1.85-2.28) 
2.54*** 
(2.13-3.03) 
1.84*** 
(1.7-1.99) 
2.28*** 
(1.98-2.61) 
-2.96*** 
(-3.28--2.64) 
-3.69*** 
(-4.24--3.13) 
Angina 
2.15*** 
(1.96-2.34) 
2.74*** 
(2.35-3.2) 
1.98*** 
(1.76-2.21) 
2.89*** 
(2.32-3.56) 
2.15*** 
(1.97-2.35) 
2.66*** 
(2.25-3.11) 
-3.49*** 
(-3.87--3.09) 
-3.79*** 
(-4.47--3.11) 
Lung Disease 
2.02*** 
(1.8-2.25) 
2.48*** 
(2.03-3.04) 
2.14*** 
(1.86-2.44) 
2.28*** 
(1.73-2.98) 
2*** 
(1.79-2.22) 
2.8*** 
(2.23-3.42) 
-2.74*** 
(-3.21--2.26) 
-3.36*** 
(-4.25--2.48) 
Asthma 
1.5*** 
(1.31-1.72) 
1.84*** 
(1.4-2.39) 
1.71*** 
(1.45-2) 
2.24*** 
(1.58-3.07) 
1.57*** 
(1.35-1.79) 
1.72*** 
(1.25-2.29) 
-2.61*** 
(-3.2--2.02) 
-3.18*** 
(-4.35--1.99) 
Hypertension 
1.04 
(0.97-1.11) 
1.05 
(0.95-1.16) 
0.98 
(0.88-1.08) 
1.09 
(0.93-1.26) 
1.05 
(0.98-1.13) 
1.02 
(0.92-1.15) 
0.01 
(-0.25-0.26) 
0.02 
(-0.32-0.38) 
Low vision 
1.28*** 
(1.19-1.36) 
1.33*** 
(1.19-1.47) 
1.23*** 
(1.11-1.35) 
1.25** 
(1.07-1.45) 
1.19*** 
(1.11-1.28) 
1.26*** 
(1.11-1.43) 
-0.89*** 
(-1.15--0.62) 
-0.94*** 
(-1.35--0.53) 
Diabetes 
1.31*** 
(1.16-1.47) 
1.38** 
(1.07-1.76) 
1.16** 
(0.97-1.35) 
1.51** 
(1.08-2.06) 
1.83*** 
(1.61-2.07) 
2.29*** 
(1.79-2.88) 
-2.26*** 
(-2.77--1.74) 
-3.4*** 
(-4.36--2.42) 
Stroke 
2.4*** 
(1.99-2.86) 
2.36*** 
(1.97-2.81) 
2.21*** 
(1.75-2.73) 
2.17*** 
(1.73-2.7) 
2.22*** 
(1.86-2.62) 
2.18*** 
(1.83-2.57) 
-4.28*** 
(-5.08--3.5) 
-4.25*** 
(-5.04--3.47) 
Twoway Interactions        
 
Hypertension×Arthritis  
0.96 
(0.83-1.11)  
1.02 
(0.83-1.23)  
0.92 
(0.79-1.06)  
0.28 
(-0.36-0.92) 
Hypertension×Angina  
0.84** 
(0.7-0.99)  
0.63*** 
(0.5-0.79)  
1.03 
(0.87-1.22)  
0.04 
(-0.71-0.78) 
Hypertension×Lung 
disease  
0.93 
(0.75-1.17)  
1.05 
(0.8-1.36)  
0.93 
(0.76-1.15)  
-0.1 
(-1.05-0.84) 
Hypertension×Asthma  
1.02 
(0.77-1.32)  
1.01 
(0.72-1.37)  
1.53*** 
(1.16-1.99)  
-1.07** 
(-2.28-0.16) 
Hypertension×low vision  
1.06 
(0.93-1.21)  
1.01 
(0.84-1.22)  
1.03 
(0.89-1.19)  
0.02 
(-0.49-0.55) 
Hypertension×diabetes  
1.25** 
(0.98-1.57)  
1.11 
(0.79-1.53)  
1.12 
(0.87-1.41)  
-0.37 
(-1.4-0.64) 
Arthritis×angina  
0.78*** 
(0.65-0.92)  
0.64*** 
(0.51-0.81)  
0.79** 
(0.67-0.93)  
0.69** 
(-0.09-1.5) 
Arthritis×Lung disease  
0.73** 
(0.57-0.9)  
0.84* 
(0.64-1.08)  
0.82** 
(0.66-1.03)  
1.17** 
(0.11-2.2) 
Arthritis×Asthma  
0.8* 
(0.59-1.05)  
0.83 
(0.59-1.14)  
0.73** 
(0.54-0.95)  
1.34** 
(0.05-2.64) 
Arthritis×Low vision  
0.82** 
(0.7-0.94)  
0.99 
(0.81-1.22)  
0.95 
(0.82-1.11)  
0.14 
(-0.5-0.78) 
Arthritis×Diabetes  
0.95 
(0.73-1.21)  
0.88 
(0.61-1.23)  
0.87 
(0.67-1.1)  
1.56** 
(0.39-2.73) 
Angina×Lung disease  
0.86* 
(0.69-1.06)  
1.17 
(0.88-1.52)  
0.78** 
(0.63-0.95)  
0.72* 
(-0.32-1.75) 
Angina×Asthma  
0.81* 
(0.6-1.06)  
0.85 
(0.61-1.13)  
0.86 
(0.65-1.1)  
0.71 
(-0.56-1.99) 
Angina× Low vision  
0.99 
(0.83-1.16)  
1.05 
(0.84-1.28)  
0.9* 
(0.75-1.05)  
-0.43 
(-1.19-0.33) 
Angina×Diabetes  
0.92 
(0.69-1.22)  
0.79* 
(0.54-1.11)  
0.96 
(0.73-1.24)  
-0.03 
(-1.3-1.23) 
Lung disease ×Asthma  
0.86 
(0.65-1.12)  
0.76** 
(0.54-1.02)  
0.9 
(0.68-1.17)  
0.54 
(-0.69-1.77) 
Lung disease×Low vision  
1.1 
(0.88-1.35)  
0.99 
(0.76-1.28)  
0.92 
(0.75-1.12)  
-0.3 
(-1.26-0.64) 
Lung disease×Diabtes  
1.05 
(0.74-1.48)  
1 
(0.66-1.45)  
0.67** 
(0.47-0.91)  
0.39 
(-1.23-1.97) 
Asthma×Low vision  
1.04 
(0.78-1.36)  
1.06 
(0.77-1.45)  
1 
(0.76-1.31)  
-0.08 
(-1.25-1.15) 
Asthma×Diabetes  
1.31 
(0.81-2.02)  
1.32 
(0.77-2.07)  
0.65** 
(0.41-0.99)  
1.26 
(-0.79-3.32) 
Low vision×Diabetes  
0.74** 
(0.57-0.92)  
0.7** 
(0.5-0.95)  
0.85* 
(0.66-1.06)  
1.73*** 
(0.71-2.73) 
Random Part                 
Country  
1.04 
(0.24-3.56) 
0.97 
(0.21-3.31) 
0.8 
(0.17-2.89) 
0.85 
(0.18-3.02) 
0.26 
(0.05-0.91) 
0.25 
(0.05-0.84) 
9.71 
(2.18-34.24) 
10.38 
(2.35-35.84) 
Province 
0.3 
(0.2-0.43) 
0.3 
(0.2-0.43) 
0.41 
(0.25-0.63) 
0.39 
(0.24-0.62) 
0.21 
(0.14-0.31) 
0.21 
(0.14-0.31) 
3.66 
(2.47-5.27) 
3.67 
(2.49-5.34) 
Individual 
na   na na  na   na  na 
116.5 
(114.7-118.4) 
116.4 
(114.5-118.2) 
Notes: * p<.1, ** p<.05, *** p<.01; Figures in the parentheses are 95% credible intervals; Adjusted ORs 
are controlled for the effects of background characteristics and health risk factors. na= not applicable. 
Estimates are obtained through MCMC algorithm available in the MLWin. 
 
